Evidence map›Paper›PMID 29785208›Full record

ArticleBiotechnology for biofuels2018

Developing cellulolytic

Zhong-Peng Guo, Julien Robin, Sophie Duquesne, Michael Joseph O'Donohue, Alain Marty, Florence Bordes

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. International journal of molecular sciences · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Frontiers in microbiology · 2020
    Review
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhong-Peng GuoLISBP, CNRS, INSA/INRA UMR 792, Université de Toulouse, 135, Avenue de Rangueil, 31077 Toulouse, France.ORCID 0000-0001-7473-2616
Julien RobinLISBP, CNRS, INSA/INRA UMR 792, Université de Toulouse, 135, Avenue de Rangueil, 31077 Toulouse, France.
Sophie DuquesneLISBP, CNRS, INSA/INRA UMR 792, Université de Toulouse, 135, Avenue de Rangueil, 31077 Toulouse, France.
Michael Joseph O'DonohueLISBP, CNRS, INSA/INRA UMR 792, Université de Toulouse, 135, Avenue de Rangueil, 31077 Toulouse, France.
Alain MartyLISBP, CNRS, INSA/INRA UMR 792, Université de Toulouse, 135, Avenue de Rangueil, 31077 Toulouse, France.
Florence BordesLISBP, CNRS, INSA/INRA UMR 792, Université de Toulouse, 135, Avenue de Rangueil, 31077 Toulouse, France.
Centre National de la Recherche Scientifique · FRLaboratoire d'Ingénierie des Systèmes Biologiques et des Procédés · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBoth industrial biotechnology and the use of cellulosic biomass as feedstock for the manufacture of various commercial goods are prominent features of the bioeconomy. In previous work, with the aim of developing a consolidated bioprocess for cellulose bioconversion, we conferred cellulolytic activity of

resultsIn the present study, we first optimized the strategy of expression of multiple cellulases and rescued selection makers to obtain an auxotrophic cellulolytic

conclusionsIn summary, this study has further demonstrated the potential of cellulolytic

Indexed as

Cellulolytic biocatalystCelluloseConsolidated bioprocessingLipidsRecombinant protein productionRicinoleic acidYarrowia lipolytica

Identifiers

PMID29785208
PMCPMC5952637
OpenAlexW2806301096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.